Medicines / Novo Nordisk India / Actrapid
ActrapidRegular Human Insulin
Actrapid is marketed by Novo Nordisk India. 3 packs on NPPA's price list for July 2026, containing Regular Human Insulin.
- Packs listed
- 3
- Lowest MRP
- ₹181.39
- Per unit
- ₹18.14 to ₹208.93
- Price-controlled packs
- 1 of 3
- Dosage forms
- 3
Packs and prices
- ₹626.78Actrapid 100 iu Flexpen 3 mlRegular Human Insulin Flexpen 100 iu · ₹208.93 per ml
- ₹181.39Actrapid Human 40 iu Injection 10 mlRegular Human Insulin Injection 40 iu · ₹18.14 per ml · price-controlled, ceiling ₹15.01 per ml
- ₹424.59Actrapid HM 100 iu Penfill 3 mlRegular Human Insulin Penfill 100 iu · ₹141.53 per ml
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Regular Human Insulin Injection 40 iu
- ₹13.00/mlInsuline Bovine · 10 ml injectionNovo Nordisk India · MRP ₹130.00 · price-controlled, ceiling ₹15.01 per ml
- ₹13.34/mlWosulin R · 15 ml injectionWockhardt · MRP ₹200.13 · price-controlled, ceiling ₹15.01 per ml
- ₹16.92/mlEquisulin R · 10 ml injectionKoye Pharmaceuticals · MRP ₹169.15 · price-controlled, ceiling ₹15.01 per ml
- ₹17.70/mlHuminsulin R · 10 ml injectionLupin · MRP ₹177.00 · price-controlled, ceiling ₹15.01 per ml
- ₹17.75/mlInsutrend R · 10 ml injectionAnthem Biopharma · MRP ₹177.50 · price-controlled, ceiling ₹15.01 per ml
- ₹17.84/mlRecosulin R · 10 ml injectionShreya Life Sciences · MRP ₹178.40 · price-controlled, ceiling ₹15.01 per ml
- ₹18.14/mlHuman Monotard · 10 ml injectionNovo Nordisk India · MRP ₹181.39 · price-controlled, ceiling ₹15.01 per ml
- ₹18.14/mlHumarap · 10 ml injectionCadila Pharmaceuticals · MRP ₹181.40 · price-controlled, ceiling ₹15.01 per ml
10 other brands of this composition on the price list; the 8 lowest per ml are shown. All Regular Human Insulin packs
The company
Novo Nordisk India has 66 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.